Pharmaceuticals · Founder · Long Time No Contact
Referral Request for Pharmaceuticals Founder: Long Time No…
Use this referral request template when you're emailing a Founder in Pharmaceuticals (long time no contact). The thread is months old. They may not remember you. You need a reason that belongs to this week, not nostalgia. Keep the note aligned with Human and specific. Peer to peer, not vendor to 'target.'
Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors
We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.
Sources: HubSpot sales email benchmarks; Gong follow-up research
Why does this referral request work for a Pharmaceuticals Founder?
- Include a forwardable paragraph.
- Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
- Fits how a founder actually reads: Short, vivid, one proof point max.
- Bring a new observation about their world, then offer a small, optional next step.
- Explain why they'd look good for making the intro.
When should I send this to a Pharmaceuticals Founder?
Ask after you've given them a reason to want to help, not after the first coffee. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a founder, Short, vivid, one proof point max. Tuesday through Thursday mid-morning local time is a safe default.
What this Founder actually cares about
A founder in Pharmaceuticals is protecting runway, focus, and the company's early reputation. They context-switch constantly and reply to emails that reduce uncertainty. They can smell a template that was also sent to 400 peers. The hook that earns a look is a problem they personally still own because the team is small. The ask should stay at this size: a yes/no on timing, or a 15-minute working chat. Delete trigger: Calling them a 'decision maker' or pitching like they're a Fortune 500 process. a problem they personally still own because the team is small
How Pharmaceuticals changes the note
Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. If you cannot name a label update, a launch window, or a congress, wait until you can. If you cannot name a label update, a launch window, or a congress, wait until you can.
How should I customize this template before I send it?
- Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
- Keep the tone human and specific.
- Don't attach a commission offer unless that's already your model.
- Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
- Don't use consumer-startup slang. It's a credibility leak.
What mistakes should I avoid with this long time no contact note?
- Asking 'who do you know?' is lazy and gets no names.
- Don't open with 'it's been a while' and then paste the old pitch.
- Don't use consumer-startup slang. It's a credibility leak.
- Calling them a 'decision maker' or pitching like they're a Fortune 500 process.
How does this long time no contact scenario compare?
| Dimension | For this template |
|---|---|
| Best send window | Only when you have a trigger |
| Ideal length | Short, vivid, one proof point max. |
| Primary ask | a yes/no on timing, or a 15-minute working chat |
| Industry metric to cite | time through MLR, access, and compliant engagement rates |
| Tone | Human and specific. Peer to peer, not vendor to 'target.' |
| Unlike no response | This isn't a 4-day bump. It's a re-introduction with a new reason. |
| Unlike breakup | You're opening a door, not closing one. Still keep it easy to ignore. |
What should I copy and send?
Copy-ready template
Subject
Could you intro me to [role] at [Company]?
Body
Hi [First Name], I'm looking for a warm intro to [specific role] who owns [pain], and you came to mind because [reason]. In Pharmaceuticals, that usually shows up as follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. If now is a bad time, don't spend political capital on this. Re-earn a conversation, not restart a stale sequence at email 4. Comfortable making that intro, or should I find another path? Best, [Your Name] [Your Title] [Your Company]
Questions people ask before they hit send
After you've created value or at least a real relationship. Right after a first meeting is usually too soon unless they offered. A good test: would they be slightly proud to put you in front of a peer? Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.
Related templates
Referral Request for Pharmaceuticals Department Head (Long Time No Contact)
Referral Request for SaaS Founder (Long Time No Contact)
Invoice Reminder for Pharmaceuticals Founder (Long Time No Contact)
Referral Request for Pharmaceuticals Founder (No Response)
Referral Request for Pharmaceuticals Founder (Replied Then Silent)
Want a custom draft instead? Try the email generator.